Top Asian Growth Companies With Insider Ownership In August 2026
In recent months, the Asian markets have been marked by a mix of volatility and opportunity, driven in part by global economic shifts and technological advancements. As investors navigate this landscape, growth companies with high insider ownership are particularly appealing due to their potential for strong alignment between management and shareholder interests.
Top 10 Growth Companies With High Insider Ownership In Asia
| Name | Insider Ownership | Earnings Growth |
| Zhejiang Taotao Vehicles (SZSE:301345) | 27.9% | 31.5% |
| Seojin SystemLtd (KOSDAQ:A178320) | 22% | 110.6% |
| SEERS (KOSDAQ:A458870) | 33.2% | 41.5% |
| Meiko Electronics (TSE:6787) | 19.2% | 28.0% |
| L&C BIOLTD (KOSDAQ:A290650) | 24% | 148.5% |
| Jiangxi Fushine Pharmaceutical (SZSE:300497) | 21.1% | 55.9% |
| Guangzhou Tinci Materials Technology (SZSE:002709) | 38.4% | 28.3% |
| Gpixel Changchun Microelectronics (SEHK:3277) | 18.2% | 34.2% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 14.1% | 41% |
| ASE Technology Holding (TWSE:3711) | 25.8% | 37.4% |
Underneath we present a selection of stocks filtered out by our screen.
SenseTime Group (SEHK:20)
Simply Wall St Growth Rating: ★★★★★☆
Overview: SenseTime Group Inc. is an investment holding company that researches, develops, and sells artificial intelligence software platforms across Mainland China, Northeast Asia, Southeast Asia, and internationally with a market cap of HK$63.12 billion.
Operations: The company's revenue primarily comes from its Software & Programming segment, which generated CN¥5.01 billion.
Insider Ownership: 20%
Revenue Growth Forecast: 22.8% p.a.
SenseTime Group is poised for significant growth, with earnings projected to increase 82.94% annually and revenue expected to grow at 22.8% per year, outpacing the Hong Kong market average. Despite this optimistic outlook, the company's Return on Equity is forecasted to be low at 2.6% in three years. Recent participation in the Macquarie Asia Conference highlights its active engagement with investors, although no substantial insider trading activity has been reported recently.
- Dive into the specifics of SenseTime Group here with our thorough growth forecast report.
- Our valuation report here indicates SenseTime Group may be overvalued.
Kingdee International Software Group (SEHK:268)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Kingdee International Software Group Company Limited is an investment holding company involved in the subscription and sale of software globally, with a market cap of approximately HK$30.41 billion.
Operations: The company's revenue segments comprise CN¥4.23 billion from subscription and software sales, and CN¥2.78 billion from implementation, consulting, and maintenance services.
Insider Ownership: 20.1%
Revenue Growth Forecast: 11.5% p.a.
Kingdee International Software Group anticipates a revenue increase of 13% to 14% for the first half of 2026, driven by its AI-first and Subscription-first strategies. The company has turned profitable, forecasting earnings growth at 31.5% annually, surpassing the Hong Kong market average. Despite trading below fair value estimates and no recent insider trading activity, its Return on Equity is projected to remain modest at 10.5%. Recent amendments to its Articles of Association were approved in May 2026.
- Get an in-depth perspective on Kingdee International Software Group's performance by reading our analyst estimates report here.
- Upon reviewing our latest valuation report, Kingdee International Software Group's share price might be too pessimistic.
Intco Medical Technology (SZSE:300677)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Intco Medical Technology Co., Ltd. focuses on the R&D, production, and marketing of medical consumables, rehabilitation equipment, and physiotherapy care products for both medical institutions and household use globally, with a market cap of CN¥32.05 billion.
Operations: Intco Medical Technology Co., Ltd. generates revenue through its operations in medical consumables, rehabilitation equipment, and physiotherapy care products for both institutional and household markets worldwide.
Insider Ownership: 36%
Revenue Growth Forecast: 16.9% p.a.
Intco Medical Technology, trading at 57.2% below its fair value estimate, is poised for significant earnings growth of 39.6% annually, outpacing the Chinese market average. Despite a forecasted low Return on Equity of 13.6%, its revenue growth rate of 16.9% exceeds market expectations. Recent product showcases at the World Health Expo highlight innovations in medical consumables and rehabilitation equipment, underscoring its strategic focus on diverse health protection solutions across various sectors.
- Unlock comprehensive insights into our analysis of Intco Medical Technology stock in this growth report.
- Our valuation report here indicates Intco Medical Technology may be undervalued.
Turning Ideas Into Actions
- Dive into all 494 of the Fast Growing Asian Companies With High Insider Ownership we have identified here.
- Curious About Other Options? The latest GPUs need a type of rare earth metal called Neodymium and there are only 29 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com